Global Preventive Healthcare Technologies and Services Market Report and Forecast 2024-2032

Global Preventive Healthcare Technologies and Services Market Outlook

The global preventive healthcare technologies and services market size was valued at USD 266.5 million in 2023, driven by the growing geriatric population and increasing prevalence of chronic diseases. The market size is anticipated to grow at a CAGR of 12.6% during the forecast period of 2024-2032 to achieve a value of USD 776.6 million by 2032.

Preventive Healthcare Technologies and Services: Introduction

Preventive healthcare technologies and services help in the early detection and prevention of medical conditions. These medical conditions can be critical or temporary. Preventive healthcare technologies are the devices used to measure health patterns such as sleep, blood pressure, heart rate, blood oxygen, and blood sugar, among other patterns. These patterns can help identify the future risks associated with current medical conditions and help prevent them. Some preventive healthcare technologies include blood pressure monitors, non-invasive glucometers, scales, step counters, digital weighing machines, and body fat analyzers.

Preventive healthcare services are practices that help prevent and detect serious medical conditions. These services include annual check-ups, vaccinations, regular screening for chronic conditions like diabetes and heart disease, immunizations against serious illnesses like flu and COVID-19, and screenings such as mammograms and colonoscopies, blood pressure, diabetes, and cholesterol tests.

Global Preventive Healthcare Technologies and Services Market Analysis

The FDA approved a new Beta Bionics iLet ACE Pump and algorithm-based software iLet Dosing Decision Software to diagnose the condition in people aged 6 years and above with diabetes. It is also announced that these will be coupled along with a compatible FDA-cleared integrated continuous glucose monitor (iCGM) to form a new system which will be known as the iLet Bionic Pancreas. This automated insulin dosing (AID) system uses an algorithm to determine insulin delivery. Such innovative developments in the field are anticipated to influence the global preventive healthcare technologies and services market growth.

The increased focus of most key players on the development of innovative technologies to reduce the hassle for the consumer and provide the best patient outcomes is a major factor driving the market growth. According to the World Health Organization, nearly 422 million people worldwide are currently suffering from diabetes. With a huge number as mentioned, the demand for these technologically advanced preventive healthcare technologies and services is also expected to increase and it will directly influence the market growth during the forecast period.

Preventive Healthcare Technologies and Services Market Segmentations

Market Breakup by Type

• Early Detection and Screening

• Vaccines

• Chronic Diseases Management

• Advanced Technologies to Reduce Errors

Market Breakup by Application

• Hospitals

• Clinics

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Preventive Healthcare Technologies and Services Market Overview

The growth of the market is driven by the increasing prevalence of chronic diseases, coupled with the rapidly rising geriatric population. With people adopting sedentary lifestyles and increasing disposable incomes in countries, especially developing countries, the market for preventive healthcare technologies and services is expected to grow at a rapid pace. Increasing technological advancements in the development of healthcare equipment are also driving market growth as they are responsible for the increased popularity of such devices and services.

Additionally, the increasing focus of market key players on the development of affordable and effective products and devices is acting as a contributing factor to the preventive healthcare technologies and services market growth. The easy availability of these preventive healthcare products has collectively contributed to the increased popularity and awareness about the benefits of using them as they save a lot of money and provide the best service at the user’s convenience.

North America is currently dominating the global market and is expected to dominate in the forecast period. The growth of the regional market is driven by the presence of some of the major key players. The presence of advanced healthcare technologies in the region and a greatly developed healthcare system are the key factors responsible for market growth. Continuous government efforts toward enlightening the regional population are also bolstering the market growth.

Preventive Healthcare Technologies and Services Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Myriad Genetics, Inc

• Quest Diagnostics Incorporated

• Medtronic

• Abbott

• Merck & Co., Inc

• GlaxoSmithKline plc

• Pfizer Inc. (U.S.)

• Omnicell, Inc

• McKesson Corporation

• Dilon Medical Technologies, Inc.

• OMRON Healthcare Europe B.V.

• Novx Systems, Corp.

• Sanofi

• Viatronix, Inc.

• Lifecom, Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report